Australia's largest medical research fund makes first investment in NZ business
Which early stage company is the lucky recipient of $8 million?
Hot Topic
ELECTIONS
© All content copyright NBR. Do not reproduce in any form without permission, even if you have a paid subscription.
Australia's Medical Research Commercialisation Fund has plugged $8 million into early-stage pharmaceutical company Kea Therapeutics.
Kea, which is developing a new drug to relieve severe pain, was spun out of the Auckland Cancer Society Research Centre and the Faculty of Medical and Health
Want to read more? It's easy.
Choose your subscription
Already have an account? Login
Smartphone Only Subscription
NZ$29.95 / monthly
Monthly Premium Online Subscription
NZ$49.95 / monthly
Smartphone Only Annual Subscription
NZ$299.00 / yearly
Yearly Premium Online Subscription
NZ$499.00 / yearly
Premium Group Membership 10 Users
NZ$385+GST / monthly
$38.5 per user - Pay by monthly credit card debitPremium Group Membership 20 Users
NZ$660+GST / monthly
$33 per user - Pay by monthly credit card debitPremium Group Membership 50 Users
NZ$1375+GST / monthly
$27.5 per user - Pay by monthly credit card debitPremium Group Membership 100 Users
NZ$2100+GST / monthly
$21 per user - Pay by monthly credit card debitYearly Premium Online Subscription + NBR Marketplace
NZ$999.00 / yearly
Individual
Group membership
NBR Marketplace
Calida Smylie
Wed, 13 Dec 2017
Wed, 13 Dec 2017
© All content copyright NBR. Do not reproduce in any form without permission, even if you have a paid subscription.
Free News Alerts
Sign up to get the latest stories and insights delivered to your inbox – free, every day.
Free News Alerts
Sign up to get the latest stories and insights delivered to your inbox – free, every day.
Australia's largest medical research fund makes first investment in NZ business
72402